statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Check out Vanguard Health Care Fund Stock Picks &raquo;

 Download GuruFolio Report of Vanguard Health Care Fund (Updated on 02/27/2024), Check out Mario Gabelli Stock Picks &raquo;

 Download...

Andreas Halvorsen's Firm Sells Out of RayzeBio Inc

Bristol Myers Squibb (NYSE: BMY) announced today that it has successfully completed its acquisition of RayzeBio, Inc. (NASDAQ: RYZB). With the completion of the acquisition, RayzeBio shares have...

Bristol Myers Squibb Completes Acquisition of RayzeBio, Adding Differentiated Actinium-Based Radiopharmaceutical Platform

Bristol Myers Squibb (NYSE: BMY) today announced that its previously announced tender offer (the Offer) to acquire all of the outstanding shares of RayzeBio, Inc. (Nasdaq: RYZB) common stock for a...

Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AMAM, JNPR, INBX, RYZB SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AMAM, JNPR, INBX, RYZB PR Newswire NEW YORK, Feb. 12, 2024 NEW YORK, Feb...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AMAM, JNPR, INBX, RYZB

Bristol Myers Squibb (NYSE: BMY) and RayzeBio, Inc. (Nasdaq: RYZB) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, in...

Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period

RayzeBio ticks higher after HSR waiting period for Bristol Myers deal expires...

RayzeBio ticks higher after HSR waiting period for Bristol Myers deal expires

NEW YORK, Feb. 10, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates KRTX, DSKE, X, RYZB

Pancreatic Cancer Treatments Poised for Major Advances in 2024 Pancreatic Cancer Treatments Poised for Major Advances in 2024 PR Newswire VANCOUVER, BC, Feb. 7, 2024 FN Media Group Presents USA News...

Pancreatic Cancer Treatments Poised for Major Advances in 2024

NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

INVESTIGATION ALERT: Halper Sadeh LLC Investigates DSKE, RYZB, GRPH, ROVR

NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...

Kuehn Law Encourages DSKE, RYZB, ROVR, and GRPH Investors to Contact Law Firm

Rayzebio, Inc. provides radiopharmaceutical medicines for cancer. It develops a pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225. The company was founded by Deborah Charych, Aaron Kantoff and Aron Royston in January 2020 and is headquartered in San Diego, CA.

Volume	282,719.00
52-Wk High	$62.51
52-Wk Low	$17.95

RYZB RayzeBio Inc.

About

Feed

News

Earnings

Fundamentals